Flubendazole Elanco 50 mg/g oral powder for pigs

国: アイルランド

言語: 英語

ソース: HPRA (Health Products Regulatory Authority)

即購入

ダウンロード 製品の特徴 (SPC)
28-07-2018
ダウンロード 公開評価報告書 (PAR)
28-07-2018
ダウンロード DSU (DSU)
20-10-2023

有効成分:

Flubendazole

から入手可能:

Elanco GmbH

ATCコード:

QP52AC12

INN(国際名):

Flubendazole

投薬量:

50 milligram(s)/gram

医薬品形態:

Oral powder

処方タイプ:

POM: Prescription Only Medicine as defined in relevant national legislation

治療領域:

flubendazole

認証ステータス:

Authorised

承認日:

2013-02-22

製品の特徴

                                Health Products Regulatory Authority
27 July 2018
CRN008DD9
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Flubendazole Elanco 50 mg/g oral powder for pigs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each g contains:
ACTIVE SUBSTANCE:
Flubendazole 50mg
EXCIPIENT(S):
Titanium dioxide (E171) 20mg
For the full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Oral Powder.
White to slightly yellow powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of helminthiasis due to mature and immature stages of the
following
nematodes of the gastro-intestinal tract:
_Ascaris suum_, (large roundworm), _Hyostrongylus rubidus_, (red
stomach worm),
_Oesophagostomum dentatum_ (nodular worm), _Trichuris suis_
(whipworm),
_Strongyloidesransomi_ (threadworm) (adult).
Flubendazole is ovicidal.
4.3 CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance or to
any of the
excipients.
Health Products Regulatory Authority
27 July 2018
CRN008DD9
Page 2 of 5
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they
increase the risk
of development of resistance and could ultimately result in
ineffective therapy:

Too frequent and repeated use of anthelmintics from the same class,
over
an extended period of time.

Underdosing, which may be due to underestimation of body weight,
misadministration of the product, or lack of calibration of the dosing
device (if any).
Suspected clinical cases of resistance to anthelmintics should be
further investigated
using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where
the results of
the test(s) strongly suggest resistance to a particular anthelmintic,
an anthelmintic
belonging to another pharmacological class and having a different mode
of action
should be used.
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
None.
Special precautions to be taken by the person administ
                                
                                完全なドキュメントを読む
                                
                            

この製品に関連するアラートを検索